Cue Biopharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cue Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Cue Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $84M, a 20% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $84M +$14M +20% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $70M +$15.2M +27.8% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $54.8M +$12.5M +29.4% Dec 31, 2021 10-K 2023-03-21
Q4 2020 $42.3M +$13.2M +45.5% Dec 31, 2020 10-K 2022-03-16
Q4 2019 $29.1M +$10.1M +53.1% Dec 31, 2019 10-K 2021-03-09
Q4 2018 $19M +$9.21M +94.1% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $9.79M Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.